This document discusses alpha blockers and central sympathoplegics. It describes the classification of alpha receptors based on selectivity, the pharmacological effects of alpha blockers including on the cardiovascular, renal, and urinary systems. Adverse effects of alpha blockers are outlined. Therapeutic uses of alpha blockers include for pheochromocytoma, hypertension, benign prostatic hypertrophy, and peripheral vascular disease. Alpha-2 selective adrenergic agonists like methyldopa and clonidine are described as central sympathoplegics. Methyldopa stimulates alpha-2 receptors in the central nervous system, lowering sympathetic outflow and reducing blood pressure and renin secretion. Its therapeutic uses include for pregnancy induced